Rapid Communication| Volume 8, ISSUE 6, P601-605, 1986

Download started.


Acute encephalopathy with hyperammonemia and dicarboxylic aciduria during calcium hopantenate therapy: A patient report

      This paper is only available as a PDF. To read, Please Download here.
      We report a 3-year-old Japanese girl who developed acute encephalopathy while receiving calcium hopantenate (Calcium D-(+)-4- (2,4-dihydroxy-3,3-dimethylbutyramido) butyrate hemihydrate). She had hyperammonemia, elevated CPK, lactic acidemia and pyruvic acidemia, however, she did not show elevated SGOT or SGPT. Calcium hopantenate has been used in Japan for the treatment of mental retardation with behavior abnormalities. Recently there have been three reports on the occurrence of Reye-like syndrome in patients receiving this drug. Clinical signs and laboratory data of these patients are similar to those of Reye syndrome. Calcium hopantenate causes pantothenic acid deficiency in the young rat, which may reduce the content of coenzyme A. If this drug decreases coenzyme A biosynthesis, it may reduce β-oxidation of fatty acids and levels of dicarboxylic acids would increase because of increasing ω-oxidation.
      We suspect that there is a possible relationship between the occurrence of acute encephalopathy and calcium hopantenate therapy.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rosenfeld RG
        • Liebvaber MI
        Acute encephalopathy in siblings, Reye's syndrome vs. salicylate intoxication.
        Am J Dis Child. 1976; 130: 295-297
        • Gerber N
        • Dickinson RG
        • Harland RC
        • et al.
        Reye-like syndrome associated with valproic acid therapy.
        J Pediatr. 1979; 95: 142-144
        • Sinniah D
        • Baskaran G
        Margosa oil poisoning as a cause of Reye's syndrome.
        Lancet. 1981; 1: 487-489
        • Task Force for Evaluation of Children's Behaviors
        A double-blind controlled study of Ca hopantenate and placebo in conformity to a rating list for the evalution of the abnormal behaviors in children (III) (in Japanese).
        Rinshou Hyoka (Tokyo). 1974; 2: 375-384
        • Nakamura T
        • Soyama K
        • Ando H
        Studies on the influence of homopantothenic acid on the hepatic coenzyme A and its precursors contents in young albino rats (in Japanese).
        Vitamins (Kyoto). 1966; 34: 505-507
        • Sugimoto T
        • Nishida N
        • Yasuhara A
        • et al.
        A case of Reye-like syndrome with dicarboxylic aciduria (in Japanese).
        Proc Jap Soc Med Mass Spectrom (Kurume). 1982; 7: 153-156
        • Sugimoto T
        • Yasuhara A
        • Nishida N
        • Sakane Y
        • Sugimoto Y
        Three cases of acute encephalopathy associated with calcium hopantenate administration (in Japanese).
        No To Hattatsu (Tokyo). 1983; 15: 258-259
        • Office for Medical Application of Research, NIH. Consensus, Conference
        Diagnosis and treatment of Reye' syndrome.
        JAMA. 1982; 246: 2441-2444
        • Przyrembel H
        • Wendel U
        • Becker K
        • et al.
        Gluundescribed metabolic disorder.
        Clin Chim Acta. 1976; 66: 227-239
        • Karpati G
        • Carpenter S
        • Endrew AG
        • et al.
        The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features.
        Neurology. 1975; 25: 16-24
        • Dosman H
        • Crawhall JC
        • Klassen GA
        • Mamer OA
        • Neumann P
        Urinary excretion of C6-C10 dicarboxylic acids in glycogen storage disease type I and III.
        Clin Chim Acta. 1974; 51: 93-101
        • Kuhara T
        • Shinka T
        • Matsumoto I
        Mass spectrometric identification of 3-hydroxy-1, 10-decane-dioic acid and 3-hydroxy-1, 12-dodecanedioic acid in urine of ketotic patients (in Japanese).
        Proc Jap Soc Med Mass Spectrom (Kurume). 1980; 5: 131-134
        • Yamada M
        • Kohashi K
        • Kawasawa S
        • Doi K
        • Ko H
        Calcium hopantenate therapy in psychiatric practice (in Japanese).
        Kiso To Rinshou (Tokyo). 1979; 13: 3935-3955
        • Togashi K
        • Miura Y
        • Ishiyama S
        • Konno K
        • Suzuki H
        Two autopsied cases of sudden death associated with calcium hopantenate.
        Brain Dev. 1984; 6: 230
        • Tsutsui Y
        • Shirasawa H
        • Oka S
        An autopsy case of Reye's syndrome occurred during administration of calcium hopantenate (in Japanese).
        Saishin-Igaku (Osaka). 1984; 39: 1679-1685